BAC
Bank of America Corporation
BAC has the edge over FHB overall, supported by stronger fundamentals and stronger modeled upside.
FHB
First Hawaiian, Inc.
FHB offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
FHB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
FHB's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like FHB.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
FHB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $22.79 | -7.6% |
| Forward | 10x | $24.67 | — |
| Current | 11x | $24.67 | — |
| Fair | 13x | $28.33 | +15% |
| Expensive | 14x | $31.75 | +29% |
Historical ranges are pointers, not guarantees.
FHB has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over FHB on the outlook, with more favorable profitability expectations.
FHB Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for FHB, but weaker profitability. However, they disagree widely on these estimates.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over FHB on earnings, with more consistent year-over-year improvement.
FHB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.42 | +8.7% |
| Q3 2026 | $2.23 | +8.8% |
| Q2 2026 | $2.30 | +19% |
| Q1 2026 | $2.28 | +24% |
| Q4 2025 | $2.20 | +23% |
| Q3 2025 | $2.05 | +17% |
| Q2 2025 | $1.94 | +12% |
| Q1 2025 | $1.84 | +5.7% |
| Q4 2024 | $1.79 | -2.7% |
FHB earned $2.23 per share over the past year, up 8.8% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over FHB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over FHB on profitability, with a higher operating margin.
FHB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $230.2M | +1.7% |
| Q2 2026 | $231.3M | +6.3% |
| Q1 2026 | $220.3M | +4.4% |
| Q4 2025 | $225.9M | +20% |
| Q3 2025 | $226.4M | +7.8% |
| Q2 2025 | $217.5M | +6.3% |
| Q1 2025 | $211M | +2.5% |
| Q4 2024 | $188.1M | -10% |
FHB's revenue has grown year over year for seven quarters in a row: $230M last quarter, up 1.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 22% | -21 points |
| Q2 2026 | 41% | +0.7 points |
| Q1 2026 | 40% | +3.2 points |
| Q4 2025 | 41% | +6.8 points |
| Q3 2025 | 42% | +6.1 points |
| Q2 2025 | 41% | +1 points |
| Q1 2025 | 36% | +2.1 points |
| Q4 2024 | 34% | +4.7 points |
FHB's operating margin was 22% last quarter, down 21 points from the same quarter a year ago, near the bottom of its range since 2019.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
FHB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $101.8M | +106% |
| Q2 2026 | $7.7M | -94% |
| Q1 2026 | $155.4M | +443% |
| Q4 2025 | $100M | -2.4% |
| Q3 2025 | $49.5M | -5.3% |
| Q2 2025 | $125.2M | +73% |
| Q1 2025 | $28.6M | -54% |
| Q4 2024 | $102.5M | +206% |
FHB's free cash flow was $365M over the past year, up 19% from the year before. Free cash flow isn't a meaningful measure for financial services companies like FHB.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over FHB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
FHB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +139K shares |
| 1 year | -2% | -2.5M shares |
| 3 years | -4.3% | -5.5M shares |
| 5 years | -5.2% | -6.7M shares |
| Available history | -8.2% | -10.9M shares |
FHB has 122M diluted shares, down 2% from a year ago, with $58M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $32M |
| Q4 2025 | $26M |
| Q3 2025 | $24M |
| Q2 2025 | $25M |
| Q1 2025 | $25M |
| Q4 2022 | — |
FHB spent $58M buying back its own shares over the past year.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
FHB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -0.6x | Net Cash |
| Q3 2025 | -0.7x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
FHB has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
FHB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.9 | Neutral |
| Stochastic | 20.0 | Neutral |
FHB's weekly RSI is 38 (neutral) and its Stochastic is 20 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
FHB PE vs Financial Services Sector
| Metric | FHB | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 15% below |
| PE % | 23 | 63 | 40 pts below |
FHB has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
FHB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.0 | 1.5% below |
| 20 week MA | $26.5 | 7% below |
| 50 week MA | $26.4 | 6.7% below |
| 100 week MA | $25.6 | 3.7% below |
| 200 week MA | $23.6 | 4.5% above |
FHB has fallen below most of its moving averages, though it's still 4.5% above its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
FHB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.9 | $23.2 | -20% |
| 2021 | $23.2 | $26.9 | +16% |
| 2022 | $26.9 | $25.5 | -5.1% |
| 2023 | $25.5 | $22.9 | -10% |
| 2024 | $22.9 | $26.0 | +14% |
| 2025 | $26.0 | $26.1 | +0.4% |
| 2026 YTD | $26.1 | $24.7 | -5.3% |
FHB has the edge over BAC on returns for 2026, with the stronger performance.